Suchergebnisse - "Usmani, Saad Z"

PubPharm (308)

51

Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Dimopoulos, M. | Oriol, A. | Nahi, H. | +19

52

Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma : Findings from the MASTER and GRIFFIN Trials

enthalten in: Transplantation and cellular therapy | 2023

von Chhabra, S. | Callander, N. | Watts, N. | +34

53

Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma : a prospective observational cohort study

enthalten in: EClinicalMedicine | 2023

von Korde, N. | Tavitian, E. | Mastey, D. | +24

54

Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma : CARTITUDE-1 2-Year Follow-Up

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Martin, T. | Usmani, S. | Berdeja, J. | +25

55

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

enthalten in: Blood | 2023

von Van Oekelen, O. | Nath, K. | Mouhieddine, T. | +20

56

Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab : part 3 of the open-label, multicenter, phase 1b PAVO study

enthalten in: Leukemia & lymphoma | 2023

von Nahi, H. | Usmani, S. | Mateos, M. | +10

57

Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Foureau, D. | Paul, B. | Guo, F. | +10

58

Cross Fire : Daratumumab-Based Therapies Are Standard of Care in Newly Diagnosed Multiple Myeloma

enthalten in: Hematology/oncology and stem cell therapy | 2023

von Korde, N. | Usmani, S.

59

Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment : Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Cohen, A. | Hari, P. | Htut, M. | +19

60

Extreme body mass index and survival in newly diagnosed multiple myeloma patients

enthalten in: Blood cancer journal | 2023

von Shah, U. | Whiting, K. | Devlin, S. | +16